Lataa...
Combined Effects of Exercise and Denosumab Treatment on Local Failure in Post-menopausal Osteoporosis–Insights from Bone Remodelling Simulations Accounting for Mineralisation and Damage
Denosumab has been shown to increase bone mineral density (BMD) and reduce the fracture risk in patients with post-menopausal osteoporosis (PMO). Increase in BMD is linked with an increase in bone matrix mineralisation due to suppression of bone remodelling. However, denosumab anti-resorptive action...
Tallennettuna:
| Julkaisussa: | Front Bioeng Biotechnol |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8212042/ https://ncbi.nlm.nih.gov/pubmed/34150724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2021.635056 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|